SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/17/20 Gevo, Inc. 10-K 12/31/19 84:7.8M RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.06M 2: EX-4.13 Instrument Defining the Rights of Security Holders HTML 40K 3: EX-23.1 Consent of Experts or Counsel HTML 25K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 31K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 31K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 28K 83: R1 Document And Entity Information HTML 65K 34: R2 Consolidated Balance Sheets HTML 100K 25: R3 Consolidated Balance Sheets (Parentheticals) HTML 33K 55: R4 Consolidated Statements of Operations HTML 80K 84: R5 Consolidated Statements of Stockholders' Equity HTML 65K 35: R6 Consolidated Statements of Cash Flows HTML 118K 26: R7 Note 1 - Nature of Business and Financial HTML 47K Condition 56: R8 Note 2 - Summary of Significant Accounting HTML 88K Policies 82: R9 Note 3 - Revenues From Contracts With Customers HTML 85K and Other Revenues 31: R10 Note 4 - Leases, Right-to-Use Assets and Related HTML 54K Liabilities 23: R11 Note 5 - Inventories HTML 46K 47: R12 Note 6 - Property, Plant and Equipment HTML 70K 73: R13 Note 7 - Embedded Derivatives HTML 53K 32: R14 Note 8 - Accounts Payable and Accrued Liabilities HTML 38K 24: R15 Note 9 - Debt HTML 127K 48: R16 Note 10 - Equity Incentive Plans HTML 36K 74: R17 Note 11 - Stock-based Compensation HTML 115K 33: R18 Note 12 - Income Taxes HTML 62K 22: R19 Note 13 - Employee Benefit Plan HTML 29K 63: R20 Note 14 - Commitments and Contingencies HTML 34K 70: R21 Note 15 - Fair Value Measurements and Fair Value HTML 92K of Financial Instruments 44: R22 Note 16 - Segments HTML 79K 18: R23 Significant Accounting Policies (Policies) HTML 189K 64: R24 Note 2 - Summary of Significant Accounting HTML 43K Policies (Tables) 71: R25 Note 3 - Revenues From Contracts With Customers HTML 71K and Other Revenues (Tables) 46: R26 Note 4 - Leases, Right-to-Use Assets and Related HTML 45K Liabilities (Tables) 19: R27 Note 5 - Inventories (Tables) HTML 47K 62: R28 Note 6 - Property, Plant and Equipment (Tables) HTML 71K 72: R29 Note 7 - Embedded Derivatives (Tables) HTML 40K 78: R30 Note 8 - Accounts Payable and Accrued Liabilities HTML 37K (Tables) 50: R31 Note 9 - Debt (Tables) HTML 96K 21: R32 Note 11 - Stock-based Compensation (Tables) HTML 109K 30: R33 Note 12 - Income Taxes (Tables) HTML 56K 76: R34 Note 15 - Fair Value Measurements and Fair Value HTML 82K of Financial Instruments (Tables) 49: R35 Note 16 - Segments (Tables) HTML 75K 20: R36 Note 1 - Nature of Business and Financial HTML 58K Condition (Details Textual) 29: R37 Note 2 - Summary of Significant Accounting HTML 66K Policies (Details Textual) 75: R38 Note 2 - Summary of Significant Accounting HTML 32K Policies - Warrants (Details) 51: R39 Note 2 - Summary of Significant Accounting HTML 39K Policies - Securities Potentially Dilute Calculation of Diluted Earnings Per Share (Details) 67: R40 Note 3 - Revenues From Contracts With Customers HTML 42K and Other Revenues (Details Textual) 58: R41 Note 3 - Revenues from Contracts with Customers HTML 44K and Other Revenues - Disaggregated Revenues (Details) 17: R42 Note 4 - Leases, Right-to-Use Assets and Related HTML 46K Liabilities (Details Textual) 43: R43 Note 4 - Leases, Right-to-Use Assets and Related HTML 44K Liabilities - Lease Costs (Details) 66: R44 Note 4 - Leases, Right-to-Use Assets and Related HTML 38K Liabilities - Future Minimum Payments Under Non-cancelable Operating Leases (Details) 57: R45 Note 5 - Inventories - Components of Inventory HTML 49K Balances (Details) 16: R46 Note 6 - Property, Plant and Equipment - Property, HTML 59K Plant and Equipment by Classification (Details) 42: R47 Note 6 - Property, Plant and Equipment - HTML 30K Depreciation and Amortization Expense (Details) 65: R48 Note 7 - Embedded Derivatives (Details Textual) HTML 43K 59: R49 Note 7 - Embedded Derivatives - Schedule of Inputs HTML 38K to Lattice Model Used to Value Embedded Derivatives (Details) 53: R50 Note 8 - Accounts Payable and Accrued Liabilities HTML 38K - Components Accounts Payable and Accrued Liabilities in Consolidated Balance Sheets (Details) 79: R51 Note 9 - Debt (Details Textual) HTML 99K 37: R52 Note 9 - Debt - Information Pertaining to HTML 69K Convertible Notes (Details) 27: R53 Note 9 - Debt - Notes Payable - Other (Details) HTML 37K 54: R54 Note 9 - Debt - Future Payments for Notes Payable HTML 42K - Other (Details) 80: R55 Note 10 - Equity Incentive Plans (Details Textual) HTML 55K 38: R56 Note 11 - Stock-based Compensation (Details HTML 60K Textual) 28: R57 Note 11 - Stock-based Compensation - Stock-Based HTML 37K Compensation Expense (Details) 52: R58 Note 11 - Stock-based Compensation - Stock Option HTML 65K Award Activity (Details) 81: R59 Note 11 - Stock-based Compensation - Non-Vested HTML 47K Restricted Stock (Details) 39: R60 Note 11 - Stock-based Compensation - Determining HTML 39K Fair Value of Share-Based Payment Awards (Details) 14: R61 Note 12 - Income Taxes (Details Textual) HTML 36K 60: R62 Note 12 - Income Taxes - Net Deferred Tax Assets HTML 44K (Details) 68: R63 Note 12 - Income Taxes - Reconciling Items from HTML 43K Income Tax Computed at the Statutory Federal Rate (Details) 40: R64 Note 14 - Commitments and Contingencies (Details HTML 30K Textual) 15: R65 Note 15 - Fair Value Measurements and Fair Value HTML 29K of Financial Instruments (Details Textual) 61: R66 Note 15 - Fair Value Measurements and Fair Value HTML 51K of Financial Instruments - Schedule of Carrying Value and Fair Value by Fair Value Hierarchy of Financial Instruments (Details) 69: R67 Note 15 - Fair Value Measurements and Fair Value HTML 36K of Financial Instruments - Schedule of Fair Value Measurements Using Level 3 Inputs (Details) 41: R68 Note 16 - Segments (Details Textual) HTML 27K 13: R69 Note 16 - Segments - Information on Business HTML 55K Segments (Details) 45: XML IDEA XML File -- Filing Summary XML 158K 77: EXCEL IDEA Workbook of Financial Reports XLSX 71K 7: EX-101.INS XBRL Instance -- gevo-20191231 XML 2.13M 9: EX-101.CAL XBRL Calculations -- gevo-20191231_cal XML 135K 10: EX-101.DEF XBRL Definitions -- gevo-20191231_def XML 1.33M 11: EX-101.LAB XBRL Labels -- gevo-20191231_lab XML 1.13M 12: EX-101.PRE XBRL Presentations -- gevo-20191231_pre XML 1.37M 8: EX-101.SCH XBRL Schema -- gevo-20191231 XSD 220K 36: ZIP XBRL Zipped Folder -- 0001437749-20-005495-xbrl Zip 187K
Exhibit 4.13
DESCRIPTION OF SECURITIES
The following summary of the terms of the capital stock of Gevo, Inc. (“we,” “our” or “us”) is based upon our amended and restated certificate of incorporation and our amended and restated bylaws. The summary is not complete and is qualified by reference to our amended and restated certificate of incorporation and our amended and restated bylaws, each of which is filed as an exhibit to this Annual Report on Form 10-K and incorporated by reference herein. We encourage you to read our amended and restated certificate of incorporation, our amended and restated bylaws and the applicable provisions of the Delaware General Corporation Law (the “DGCL”) for additional information.
Authorized and Outstanding Capital Stock
Our authorized capital stock consists of 250,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share, issuable in one or more series designated by our board of directors.
Common Stock
The holders of our common stock have one vote per share. Holders of common stock are not entitled to vote cumulatively for the election of directors. Generally, all matters to be voted on by stockholders must be approved by a majority, or, in the case of election of directors, by a plurality, of the votes cast at a meeting at which a quorum is present, voting together as a single class, subject to any voting rights granted to holders of any then outstanding preferred stock. Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to participate equally in dividends when and as dividends may be declared by our board of directors out of funds legally available for the payment of dividends. In the event of our voluntary or involuntary liquidation, dissolution or winding up, the prior rights of our creditors and the liquidation preference of any preferred stock then outstanding must first be satisfied. The holders of common stock will be entitled to share in the remaining assets on a pro rata basis. No shares of common stock are subject to redemption or have redemptive rights to purchase additional shares of common stock.
Our common stock is listed on the Nasdaq Capital Market under the symbol “GEVO.”
Preferred Stock
Our amended and restated certificate of incorporation provides that we may issue shares of preferred stock from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, qualifications, limitations and restrictions thereof, applicable to the shares of each series of preferred stock. Our board of directors may, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of our common stock, including the likelihood that such holders will receive dividend payments and payments upon liquidation, and could have anti-takeover effects, including preferred stock or rights to acquire preferred stock in connection with implementing a stockholder rights plan. The ability of our board of directors to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control or the removal of our existing management. There are currently no shares of preferred stock outstanding.
Anti-Takeover Provisions
The DGCL, our amended and restated certificate of incorporation, and our amended and restated bylaws contain provisions that could discourage or make more difficult a change in control of us, including an acquisition of us by means of a tender offer, a proxy contest and removal of our incumbent officers and directors, without the support of our board of directors. A summary of these provisions follows.
Statutory Business Combination Provision
We are subject to Section 203 of the DGCL, which, subject to certain exceptions, prohibits a Delaware corporation from engaging in any “business combination” with an “interested stockholder” for a period of three years following the time that such stockholder became an interested stockholder, unless:
● |
the board of directors of the corporation approves either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder, prior to the time the interested stockholder attained that status; |
● |
upon the closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding, for purposes of determining the number of shares outstanding, those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or |
● |
at or subsequent to such time, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock that is not owned by the interested stockholder. |
With certain exceptions, an “interested stockholder” is a person or group who or which owns 15% or more of the corporation’s outstanding voting stock (including any rights to acquire stock pursuant to an option, warrant, agreement, arrangement or understanding, or upon the exercise of conversion or exchange rights, and stock with respect to which the person has voting rights only), or is an affiliate or associate of the corporation and was the owner of 15% or more of such voting stock at any time within the previous three years.
In general, Section 203 defines a business combination to include:
● |
any merger or consolidation involving the corporation and the interested stockholder; |
● |
any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; |
● |
subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |
● |
any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or |
● |
the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. |
A Delaware corporation may “opt out” of this provision with an express provision in its original certificate of incorporation or an express provision in its amended and restated certificate of incorporation or bylaws resulting from a stockholders’ amendment approved by at least a majority of the outstanding voting shares. However, we have not “opted out” of this provision. Section 203 could prohibit or delay mergers or other takeover or change-in-control attempts and, accordingly, may discourage attempts to acquire us.
Election and Removal of Directors
Our amended and restated certificate of incorporation provides for our board of directors to be divided into three classes, with staggered three-year terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding are able to elect all of our directors. Directors may be removed only with cause by the affirmative vote of the holders of at least a majority of the outstanding shares entitled to vote on such removal.
No Stockholder Action by Written Consent
Our amended and restated certificate of incorporation and our amended and restated bylaws provide that any action required or permitted to be taken by the holders of common stock at an annual or special meeting of stockholders must be effected at a duly called meeting and may not be taken or effected by written consent of the stockholders.
Stockholder Meetings
Under our amended and restated certificate of incorporation and our amended and restated bylaws, only our board of directors, acting pursuant to a resolution adopted by a majority of the directors then in office, may call a special meeting of the stockholders, and any business conducted at any special meeting will be limited to the purpose or purposes specified in the notice for such special meeting.
Requirements for Advance Notification of Stockholder Nominations and Proposals
In order for our stockholders to bring nominations or business before an annual meeting properly, they must comply with certain notice requirements as provided by our amended and restated bylaws. Typically, in order for such notices to be timely, they must be provided to us not earlier than the close of business on the 120th day prior to the one-year anniversary of the preceding year’s annual meeting and not later than the close of business on the 90th day prior to the one-year anniversary of the preceding year’s annual meeting. For such notices to be timely in the event the annual meeting is advanced more than 30 days prior to or delayed by more than 70 days after the one-year anniversary of the preceding year’s annual meeting, notice must be provided to us not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public announcement of the date of such meeting is first made.
Amendment of Charter Provisions
The affirmative vote of the holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of our voting stock, voting together as a single class, is required to, among other things, alter, amend or repeal certain provisions of our amended and restated certificate of incorporation, including those related to the classification of our board of directors, the amendment of our bylaws and certificate of incorporation, restrictions against stockholder actions by written consent, the designated parties entitled to call a special meeting of the stockholders and the indemnification of officers and directors.
Our amended and restated bylaws may only be amended (or new bylaws adopted) by our board of directors or the affirmative vote of the holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of our voting stock.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company. Its address is 6201 15th Avenue, Brooklyn, New York 11219 and its telephone number is (718) 921-8300.
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/17/20 | 8-K | ||
For Period end: | 12/31/19 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/06/22 Gevo, Inc. 424B5 2:484K RDG Filings/FA 2/24/22 Gevo, Inc. 10-K 12/31/21 118:12M RDG Filings/FA 9/09/21 Gevo, Inc. 424B5 1:372K RDG Filings/FA 7/16/21 Gevo, Inc. S-8 7/16/21 3:90K RDG Filings/FA 5/14/21 Gevo, Inc. 10-Q 3/31/21 76:5.7M RDG Filings/FA 3/18/21 Gevo, Inc. 10-K 12/31/20 89:9.1M RDG Filings/FA 1/21/21 Gevo, Inc. 424B5 1:575K RDG Filings/FA 1/19/21 Gevo, Inc. S-3ASR 1/19/21 3:326K RDG Filings/FA 12/30/20 Gevo, Inc. 424B5 1:550K RDG Filings/FA 8/24/20 Gevo, Inc. 424B5 1:707K RDG Filings/FA |